Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Vicca, S; Bahn, M; Estiarte, M; van Loon, E E; Vargas, R; Alberti, G; Ambus, P; Arain, M A; Beier, C; Bentley, L P; Borken, W; Buchmann, N; Collins, S L; de Dato, G; Dukes, J S; Escolar, C; Fay, P; Guidolotti, G; Hanson, P J; Kahmen, A; Kröel-Dulay, G; Ladreiter-Knauss, T; Larsen, K S; Lellei-Kovacs, E; Lebrija-Trejos, E; Maestre, F T; Marhan, S; Marshall, M; Meir, P; Miao, Y; Muhr, J; Niklaus, P A; Ogaya, R; Peñuelas, J; Poll, C; Rustad, L E; Savage, K; Schindlbacher, A; Schmidt, I K; Smith, A R; Sotta, E D; Suseela, V; Tietema, A; van Gestel, N; van Straaten, O; Wan, S; Weber, U; Janssens, I A (2014). Can current moisture responses predict soil CO2 efflux under altered precipitation regimes? A synthesis of manipulation experiments. Biogeosciences, 11(11):2991-3013.

Dedes, K J; Natrajan, R; Lambros, M B; Geyer, F C; Lopez-Garcia, M A; Savage, K; Jones, R L; Reis-Filho, J S (2011). Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. European Journal of Cancer, 47(1):138-150.

Dedes, K J; Lopez-Garcia, M A; Geyer, F C; Lambros, M B K; Savage, K; Vatcheva, R; Wilkerson, P; Wetterskog, D; Lacroix-Triki, M; Natrajan, R; Reis-Filho, J S (2010). Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study. Breast Cancer Research and Treatment, 124(3):653-666.

Lambros, M B; Natrajan, R; Geyer, F C; Lopez-Garcia, M A; Dedes, K J; Savage, K; Lacroix-Triki, M; Jones, R L; Lord, C J; Linardopoulos, S; Ashworth, A; Reis-Filho, J S (2010). PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study. Modern Pathology, 23(10):1334-1345.

Dedes, K J; Wetterskog, D; Mendes-Pereira, A M; Natrajan, R; Lambros, M B; Geyer, F C; Vatcheva, R; Savage, K; Mackay, A; Lord, C J; Ashworth, A; Reis-Filho, J S (2010). PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors. Science Translational Medicine, 2(53):53ra75.

This list was generated on Mon Nov 20 02:16:08 2017 CET.